28th May, 2021
Gujarat will play an important role in the production of Bharat Biotech's Coronavirus vaccine. Gujarat Biotechnology Research Center has entered into an agreement with Bharat Biotech, under which Gujarat will produce vaccine substances. This research lab of Gujarat has so far produced 1100 SARS Covid genome sequences.
From August 2021, Gujarat Biotechnology will start production, increasing the production capacity of India Biotech to 20 million per month. Chief Minister Vijay Rupani said after this MoU that Gujarat is going to play an important role in the production of the Corona vaccine. Earlier, Gujarat Biotechnology also studied the origin of Kovid-19, its mutations, the effect of the corona vaccine, and adverse effects of corona in people.
Important role of drug substance
Rupani said that the role of drug substance is important in the manufacture of vaccine and Gujarat will participate in it. Vaccine manufacturing is a complex and lengthy process, if all goes well, India Biotech's vaccine production capacity will increase to 20 million per month due to drug substations produced by Gujarat Biotechnology in August 2021.
Setting up 3 laboratories for substrate production
Gujarat will set up the Biosafety Level 3 Laboratory for the production of substances. It was the second lab in India to produce 1100 genome sequences of the coronavirus in April 2020. Following the recommendation of the Ministry of AYUSH, Gujarat Biotechnology has studied the effect of more than 200 medicines of Ayurveda on the corona. Gujarat Biotechnology has used Hester Biosciences Pvt Ltd, Supratech Laboratory, and Vacatia to prepare the coronavirus vaccine and its diagnostic. MoU has also been done with Health Care.